Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Purchase of 83,333 BRVE shares, $1.50M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Braveheart Bio, Inc. (BRVE) | Purchase | 83,333 | $1.50M |
| Feb 18, 2026 | BIOGEN INC. (BIIB) | Grant/Award | 38,015 | n/a |
| Feb 10, 2026 | BIOGEN INC. (BIIB) | Exercise/Conversion | 9,008 | n/a |
| Dec 3, 2025 | BIOGEN INC. (BIIB) | Exercise/Conversion | 7,040 | n/a |
| Feb 10, 2025 | BIOGEN INC. (BIIB) | Exercise/Conversion | 9,008 | n/a |
| Feb 10, 2024 | BIOGEN INC. (BIIB) | Grant/Award | 27,025 | n/a |
| Dec 5, 2022 | BIOGEN INC. (BIIB) | Grant/Award | 80,522 | n/a |